Prostate cancer is the second leading cause of cancer death in men in the U.S., with an expected 288,000 cases and 34,700 deaths expected in 2023, per the American Cancer Society. As artificial ...
MINNEAPOLIS, Feb. 25, 2025 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of ...
Francis Medical has just received a fresh infusion of cash on its journey to treat prostate cancer. This week, the Maple Grove-based company announced that it has closed on an $80 million Series C ...
The U.S. Food and Drug Administration is expediting the review process for Francis Medical’s prostate cancer therapy technology, a process that happens when a new treatment could be more effective ...
SYDNEY--(BUSINESS WIRE)--AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced $18M in Australian Federal Government Funding from the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Francis Medical, Inc. has ...
PHILADELPHIA (KYW Newsradio) — Prostate cancer is the second most common cancer-related cause of death among men in the United States. Over many years, numerous cases involving the prostate-specific ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Profound Medical ( (TSE:PRN)) just ...
COLORADO SPRINGS, Colo. (KRDO) – On Friday, former President Joe Biden announced that he'd been diagnosed with an "aggressive form" of prostate cancer, which has spread to his bones. The news sparked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback